Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 7/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13425661 | 0.95 | GAA (0.65) | GAAMEN1KMT2APDE1CNPC1 | |
| SCHEMBL3398322 | 0.91 | GAA (0.59) | GAAMEN1KMT2APDE1CNPC1 | |
| SCHEMBL3395486 | 0.90 | GAA (0.57) | GAAMEN1KMT2APDE1CADORA2B | |
| SCHEMBL3396532 | 0.89 | GAA (0.62) | GAAMEN1KMT2APDE1CADORA2B | |
| SCHEMBL3394396 | 0.89 | MEN1 (0.58) | GAAMEN1KMT2APDE1CADORA2B | |
| SCHEMBL3395293 | 0.88 | GAA (0.57) | GAAMEN1KMT2APDE1CNPC1 | |
| SCHEMBL13425377 | 0.88 | GAA (0.68) | GAAMEN1KMT2APDE1CNPC1 | |
| SCHEMBL3397339 | 0.87 | GAA (0.60) | GAAMEN1KMT2APDE1CADORA2B | |
| SCHEMBL3434652 | 0.86 | MEN1 (0.64) | GAAMEN1KMT2APDE1CADORA2B | |
| SCHEMBL3394409 | 0.86 | MEN1 (0.55) | GAAMEN1KMT2APDE1CADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010046780-A2 | ANTI VIRAL COMPOUNDS | INSTITUT PASTEUR KOREA (KR) | 2010-04-29 | — | — | WO | disclosed |
| WO-2010046780-A2 | ANTI VIRAL COMPOUNDS | INSTITUT PASTEUR KOREA (KR) | 2010-04-29 | — | — | WO | disclosed |